country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-118569

Copy Link Print Information

CP-115953

CP-115953 is an antitumor fluoroquinolone compound that targets eukaryotic topoisomerase II and Escherichia coli DNA gyrase. CP-115953 inhibits ATP hydrolysis and DNA relaxation by stimulating enzyme-mediated DNA cleavage, and enhances the expression of immune-related cytokines. CP-115953 is applicable for research on human cancers.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 136440-70-5
分子式: C₁₉H₁₃F₂NO₄
分子量:357.31

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

CP-115953 構造式

CAS 番号: 136440-70-5

価格（税別）

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性
- 製品説明
- IC₅₀ & Target
- Cellular Effect
- 体外実験
化学情報
純度とドキュメンテーション
参考文献
Calculators
Help & FAQs
関連分類
Bioz

生物活性

製品説明

IC₅₀ & Target

^[1]

Topoisomerase II

Topoisomerase アイソフォーム固有の製品をすべて表示 :

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
CHO	IC50	6 μM	Cytotoxicity against wild-type Chinese hamster ovary cells assessed as reduction in cell survival via colony-forming cytotoxicity assay with 1 h treatment followed by 5 days incubation in fresh medium. Cytotoxicity against wild-type Chinese hamster ovary cells assessed as reduction in cell survival via colony-forming cytotoxicity assay with 1 h treatment followed by 5 days incubation in fresh medium.	8385484
CHO	EC50	9 μM	Cytotoxicity against wild-type Chinese hamster ovary (CHO) cells assessed via colony-forming assay. Cytotoxicity against wild-type Chinese hamster ovary (CHO) cells assessed via colony-forming assay.	9062121
CHO	EC50	12 μM	Cytotoxicity against Vpm^R-5 mutant Chinese hamster ovary (CHO) cells assessed via colony-forming assay. Cytotoxicity against Vpm^R-5 mutant Chinese hamster ovary (CHO) cells assessed via colony-forming assay.	9062121

体外実験

CP-115953 (0.78-100 μM; 96 h) inhibits the proliferation of PHA-stimulated human peripheral blood lymphocytes, with an EC₅₀ of 3.1 μM after 96 h of incubation^[6].
CP-115953 (0.78-100 μM; 96 h) inhibits DNA synthesis in human peripheral blood lymphocytes stimulated by Phytohemagglutinin (PHA) (HY-N7038) in a dose-dependent manner^[6].

CP-115953 (0.78-100 μM; 48 h) stimulates IL-2 production in PHA-stimulated human peripheral blood lymphocytes in a dose-dependent manner^[6].
CP-115953 (6.25-50 μM; 48 h) modulates IFN-γ production and cytokine mRNA expression in PHA-stimulated human peripheral blood lymphocytes^[6].
CP-115953 (6 min) potently enhances Drosophila melanogaster topoisomerase II-mediated DNA cleavage, with an EC₂ of 5 μM^[3].
CP-115953 (up to 20 min) inhibits ATP hydrolysis catalyzed by Drosophila melanogaster topoisomerase II, with an IC₅₀ value of 110 μM^[3].
CP-115953 (50 μM; 6 min) exhibits DNA cleavage-enhancing activity against Drosophila melanogaster topoisomerase II^[3].
CP-115953 potently enhances calf thymus topoisomerase II-mediated DNA cleavage, with an EC₂ of 0.3 μM^[4].
CP-115953 (15 min) inhibits calf thymus topoisomerase II-mediated DNA relaxation, with an IC₅₀ of 3.2 μM^[4].
CP-115953 (50 μM) does not significantly inhibit the strand-passing DNA ligation mediated by purified Drosophila melanogaster topoisomerase II^[1].
CP-115953 (6 min) enhances the post-strand-passage double-stranded DNA cleavage mediated by purified Drosophila melanogaster topoisomerase II^[1].
CP-115953 (15 min) inhibits DNA relaxation mediated by purified Drosophila melanogaster topoisomerase II, with an IC₅₀ of approximately 50 μM^[1].
CP-115953 (50 μM; 6 min) increases the level of Drosophila melanogaster topoisomerase II-DNA cleavage complexes without inhibiting enzyme-mediated DNA ligation^[2].
CP-115953 (1 h) potently kills wild-type Chinese hamster ovary (CHO) cells, with an EC₅₀ of approximately 9 μM^[4].
CP-115953 (1 h) potently kills human A-431 squamous carcinoma cells, with an EC₅₀ of approximately 14 μM^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[6]

Cell Line:

human peripheral blood lymphocytes
Concentration:

0.78, 1.6, 3.1, 6.2, 12.5, 25, 50, 100 μM
Incubation Time:

48, 72, 96 h
Result:

Inhibited DNA synthesis in human peripheral blood lymphocytes stimulated by Phytohemagglutinin (PHA).

化学情報

CAS 番号 136440-70-5
分子量 357.31
分子式 C₁₉H₁₃F₂NO₄
SMILES

O=C(C1=CN(C2CC2)C3=C(C=C(F)C(C4=CC=C(O)C=C4)=C3F)C1=O)O
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

取扱説明書 (2659 KB)

参考文献

[1]. Robinson MJ, et al. Effects of quinolone derivatives on eukaryotic topoisomerase II. A novel mechanism for enhancement of enzyme-mediated DNA cleavage. J Biol Chem. 1991 Aug 5;266(22):14585-92. [Content Brief]

[2]. Robinson MJ, et al. Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group. Antimicrobial agents and chemotherapy. 1992 Apr;36(4):751-6.

[3]. Robinson MJ, et al. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II. Biochemistry. 1993 Apr 13;32(14):3638-43.

[4]. Elsea SH, et al. Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential. Antimicrobial agents and chemotherapy. 1993 Oct;37(10):2179-86.

[5]. Elsea SH, et al. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs. Biochemistry. 1997 Mar 11;36(10):2919-24. [Content Brief]

[6]. Riesbeck K, et al. CP-115,953 stimulates cytokine production by lymphocytes. Antimicrob Agents Chemother. 1995 Feb;39(2):476-83.

[7]. Elsea SH, et al. A yeast type II topoisomerase selected for resistance to quinolones. Mutation of histidine 1012 to tyrosine confers resistance to nonintercalative drugs but hypersensitivity to ellipticine. J Biol Chem. 1995 Jan 27;270(4):1913-20.

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ

Amount: USD 0.00

生物活性
- 製品説明
- IC₅₀ & Target
- 体外実験
化学情報
純度とドキュメンテーション
参考文献

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

CP-115953

Topoisomerase アイソフォーム固有の製品をすべて表示

DNA/RNA Synthesis アイソフォーム固有の製品をすべて表示